← Leaderboards
Hugh Lee Sweeney
University Of Pennsylvania
$44,337,022
Attributed
$45,494,120
Total exposure
39
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$92,340,704 · 44
By mechanism
U54$51,911,070 · 12
R01$21,138,857 · 8
P50$11,411,439 · 10
P01$5,452,169 · 7
R33$973,747 · 1
T32$530,051 · 1
Top collaborators
- Theodore M Kamenecka4 shared
- Courtney A Miller4 shared
- Gavin R Rumbaugh4 shared
- Louis Daniel Scampavia4 shared
- Timothy Patrick Spicer4 shared
- Elizabeth M Mcnally1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Glenn Walter$7,015,730
- Elisabeth R Barton$7,676,702
- Joshua T Selsby$1,815,522
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMuscleMuscular DystrophiesActinsLeadMouse ModelInflammationDesignPharmaceutical PreparationsMutationMyosin AtpaseNatural RegenerationIn VitroStructureMyocardiumFibrosisRepairedGene TherapyProteinsInsightPreventDisease ProgressionMotorFunding
Grant awards (161)
Addressing Shortcomings of AAV GeneTherapies for the Muscular Dystrophies$1,347,536
P50 · FY2025 · HD · contact PI
Project 1 - Sweeney_Hammers$262,991
P50 · FY2025 · HD · contact PI
Admin Core - Sweeney_McNally(NU)$25,571
P50 · FY2025 · HD · contact PI
Understanding and Improving Therapies for the Muscular Dystrophies$1,546,142
P50 · FY2024 · AR · contact PI
Modifying heart and skeletal muscle in muscular dystrophy$486,520
P50 · FY2024 · AR · contact PI
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma$475,793
R33 · FY2024 · NS
Myosin 18 and its role in skeletal muscle$400,428
R01 · FY2024 · AR · contact PI
Potential therapies for the muscular dystrophies$358,894
P50 · FY2024 · AR · contact PI
Core A - Admin Core$30,822
P50 · FY2024 · AR · contact PI
Understanding and Improving Therapies for the Muscular Dystrophies$1,549,615
P50 · FY2023 · AR · contact PI
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma$497,954
R33 · FY2023 · NS
Modifying heart and skeletal muscle in muscular dystrophy$486,520
P50 · FY2023 · AR · contact PI
Myosin 18 and its role in skeletal muscle$412,813
R01 · FY2023 · AR · contact PI
Myo10-Driven Filopodia in Skeletal Muscle$375,996
R01 · FY2023 · AR · contact PI
Potential therapies for the muscular dystrophies$358,894
P50 · FY2023 · AR · contact PI
Core A - Admin Core$34,295
P50 · FY2023 · AR · contact PI
Understanding and Improving Therapies for the Muscular Dystrophies$1,549,615
P50 · FY2022 · AR · contact PI
Modifying heart and skeletal muscle in muscular dystrophy$486,520
P50 · FY2022 · AR · contact PI
Myosin 18 and its role in skeletal muscle$408,684
R01 · FY2022 · AR · contact PI
Myo10-Driven Filopodia in Skeletal Muscle$372,236
R01 · FY2022 · AR · contact PI
Potential therapies for the muscular dystrophies$358,894
P50 · FY2022 · AR · contact PI
Structure and Function of Myosin VI$351,056
R01 · FY2022 · DC · contact PI
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma$229,400
R61 · FY2022 · NS
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma$185,371
R61 · FY2022 · NS
Core A - Admin Core$34,295
P50 · FY2022 · AR · contact PI
Understanding and Improving Therapies for the Muscular Dystrophies$1,588,673
P50 · FY2021 · AR · contact PI
Modifying heart and skeletal muscle in muscular dystrophy$512,453
P50 · FY2021 · AR · contact PI
Myosin 18 and its role in skeletal muscle$400,428
R01 · FY2021 · AR · contact PI
Myo10-Driven Filopodia in Skeletal Muscle$364,716
R01 · FY2021 · AR · contact PI
Potential therapies for the muscular dystrophies$358,894
P50 · FY2021 · AR · contact PI
Structure and Function of Myosin VI$351,056
R01 · FY2021 · DC · contact PI
Core A - Admin Core$34,295
P50 · FY2021 · AR · contact PI
Myosin 18 and its role in skeletal muscle$425,938
R01 · FY2020 · AR · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat - Administrative Supplement$403,938
U54 · FY2020 · AR · contact PI
Myo10-Driven Filopodia in Skeletal Muscle$375,996
R01 · FY2020 · AR · contact PI
Structure and Function of Myosin VI$351,056
R01 · FY2020 · DC · contact PI
FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES: INFLAMMATION, FIBROSIS AND FAT$1,504,473
U54 · FY2019 · AR · contact PI
Assessing and Modulating inflammation and Fibrosis in Dystrophic Muscle$530,344
U54 · FY2019 · AR · contact PI
Myo10-Driven Filopodia in Skeletal Muscle$375,996
R01 · FY2019 · AR · contact PI
Structure and Function of Myosin VI$351,056
R01 · FY2019 · DC · contact PI
MAPPING MODIFIERS OF CARDIOMYOPATHY IN MUSCULAR DYSTROPHY$273,443
U54 · FY2019 · AR · contact PI
FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES: INFLAMMATION, FIBROSIS AND FAT$1,513,351
U54 · FY2018 · AR · contact PI
Assessing and Modulating inflammation and Fibrosis in Dystrophic Muscle$534,097
U54 · FY2018 · AR · contact PI
Structure and Function of Myosin VI$366,938
R01 · FY2018 · DC · contact PI
MAPPING MODIFIERS OF CARDIOMYOPATHY IN MUSCULAR DYSTROPHY$278,568
U54 · FY2018 · AR · contact PI
FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES: INFLAMMATION, FIBROSIS AND FAT$1,522,536
U54 · FY2017 · AR · contact PI
Assessing and Modulating inflammation and Fibrosis in Dystrophic Muscle$538,141
U54 · FY2017 · AR · contact PI
MAPPING MODIFIERS OF CARDIOMYOPATHY IN MUSCULAR DYSTROPHY$283,710
U54 · FY2017 · AR · contact PI
FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES: INFLAMMATION, FIBROSIS AND FAT$1,533,675
U54 · FY2016 · AR · contact PI
Myosin Mutations Leading to Vascular Diseases$555,833
P01 · FY2016 · HL · contact PI
Assessing and Modulating inflammation and Fibrosis in Dystrophic Muscle$541,096
U54 · FY2016 · AR · contact PI
Structure and function of Myosin VI$431,310
R01 · FY2016 · DC · contact PI
MAPPING MODIFIERS OF CARDIOMYOPATHY IN MUSCULAR DYSTROPHY$288,703
U54 · FY2016 · AR · contact PI
FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES: INFLAMMATION, FIBROSIS AND FAT$1,597,511
U54 · FY2015 · AR · contact PI
Assessing and Modulating inflammation and Fibrosis in Dystrophic Muscle$556,465
U54 · FY2015 · AR · contact PI
Myosin Mutations Leading to Vascular Diseases$441,673
P01 · FY2015 · HL · contact PI
Structure and function of Myosin VI$439,497
R01 · FY2015 · DC · contact PI
MAPPING MODIFIERS OF CARDIOMYOPATHY IN MUSCULAR DYSTROPHY$306,050
U54 · FY2015 · AR · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$1,617,974
U54 · FY2014 · AR · contact PI
Structure and function of Myosin VI$454,177
R01 · FY2014 · DC · contact PI
Myosin Mutations Leading to Vascular Diseases$432,771
P01 · FY2014 · HL · contact PI
Co-Fund NIHLBI$400,000
U54 · FY2014 · AR · contact PI
Assessing and Modulating the role of inflammation and Fibrosis in the Dystrophic$248,950
U54 · FY2014 · AR · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$1,553,843
U54 · FY2013 · AR · contact PI
Structure and function of Myosin VI$431,469
R01 · FY2013 · DC · contact PI
Co-Fund NIHLBI$380,000
U54 · FY2013 · AR · contact PI
Myosin Mutations Leading to Vascular Diseases$376,910
P01 · FY2013 · HL · contact PI
Assessing and Modulating the role of inflammation and Fibrosis in the Dystrophic$315,816
U54 · FY2013 · AR · contact PI
Cellular models of microvillus inclusion disease$231,600
R21 · FY2013 · DK · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$1,645,986
U54 · FY2012 · AR · contact PI
Structure and function of Myosin VI$469,177
R01 · FY2012 · DC · contact PI
Assessing and Modulating the role of inflammation and Fibrosis in the Dystrophic$451,620
U54 · FY2012 · AR · contact PI
CO_FUND$400,000
U54 · FY2012 · AR · contact PI
Cellular models of microvillus inclusion disease$200,000
R21 · FY2012 · DK · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$23,683
U54 · FY2012 · AR · contact PI
Development of small molecules for delaying the progression of muscular dystrophy$3,114,403
U54 · FY2011 · NS · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$1,586,518
U54 · FY2011 · AR · contact PI
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys$519,110
U54 · FY2011 · NS · contact PI
Structure and function of Myosin VI$401,242
R01 · FY2011 · DC · contact PI
CO_FUND$400,000
U54 · FY2011 · AR · contact PI
Assessing and Modulating the role of inflammation and Fibrosis in the Dystrophic$349,977
U54 · FY2011 · AR · contact PI
Efficacy Assessment Core$119,327
U54 · FY2011 · NS · contact PI
Development of novel small molecules for delaying the progression of muscular dy$3,067,726
U54 · FY2010 · NS · contact PI
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat$1,616,993
U54 · FY2010 · AR · contact PI
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys$514,797
U54 · FY2010 · NS · contact PI
Myosin Isozymes$472,912
R01 · FY2010 · AR · contact PI
Assessing and Modulating the role of inflammation and Fibrosis in the Dystrophic$424,013
U54 · FY2010 · AR · contact PI
NHLBI Co-funding (Budget Period 06)$408,173
U54 · FY2010 · AR · contact PI
Structure and function of Myosin VI$405,295
R01 · FY2010 · DC · contact PI
Efficacy Assessment Core$115,727
U54 · FY2010 · NS · contact PI
Development of novel small molecules for delaying the progression of muscular dy$3,022,413
U54 · FY2009 · NS · contact PI
Modulation of Muscle Growth for the Muscular Dystrophies$1,558,924
U54 · FY2009 · AR · contact PI
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys$510,603
U54 · FY2009 · NS · contact PI
Protease Inhibition as Possible therapy for Muscular Dystrophy$470,464
U54 · FY2009 · AR · contact PI
Myosin Isozymes$464,670
R01 · FY2009 · AR · contact PI
Structure and function of Myosin VI$400,402
R01 · FY2009 · DC · contact PI
Efficacy Assessment Core$112,236
U54 · FY2009 · NS · contact PI
Development of novel small molecules for delaying the progression of muscular dy$2,978,431
U54 · FY2008 · NS · contact PI
Modulation of Muscle Growth for the Muscular Dystrophies$1,558,924
U54 · FY2008 · AR · contact PI
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys$506,517
U54 · FY2008 · NS · contact PI
Protease Inhibition as Possible therapy for Muscular Dystrophy$470,464
U54 · FY2008 · AR · contact PI
Myosin Isozymes$452,027
R01 · FY2008 · AR · contact PI
CARDIAC GENE THERAPY$436,564
P01 · FY2008 · HL · contact PI
Structure and function of Myosin VI$391,667
R01 · FY2008 · DC · contact PI
Regulation and Mechano-Chemistry of Myosins V and VI$262,228
P01 · FY2008 · AR · contact PI
Efficacy Assessment Core$108,825
U54 · FY2008 · NS · contact PI
Development of novel small molecules for delaying the progression of muscular dy$2,934,156
U54 · FY2007 · NS · contact PI
Modulation of Muscle Growth for the Muscular Dystrophies$1,559,950
U54 · FY2007 · AR · contact PI
Development of Novel Small Molecules for Delaying the Progression of Muscular Dys$536,586
U54 · FY2007 · NS · contact PI
Myosin Isozymes$448,729
R01 · FY2007 · AR · contact PI
CARDIAC GENE THERAPY$435,000
P01 · FY2007 · HL · contact PI
Protease Inhibition as Possible therapy for Muscular Dystrophy$408,273
U54 · FY2007 · AR · contact PI
Structure and function of Myosin VI$403,242
R01 · FY2007 · DC · contact PI
Understanding and Preventing Disuse Atrophy$336,267
R01 · FY2007 · AR · contact PI
Regulation and Mechano-Chemistry of Myosins V and VI$243,660
P01 · FY2007 · AR · contact PI
Efficacy Assessment Core$228,582
U54 · FY2007 · NS · contact PI
Administrative & Training Core$194,475
U54 · FY2007 · AR · contact PI
Modulation of Muscle Growth for the Muscular Dystrophies$1,608,144
U54 · FY2006 · AR · contact PI
Myosin Isozymes$462,972
R01 · FY2006 · AR · contact PI
CARDIAC GENE THERAPY$421,599
P01 · FY2006 · HL · contact PI
Structure and Function of Myosin VI$395,290
R01 · FY2006 · AR · contact PI
Understanding and Preventing Disuse Atrophy$346,310
R01 · FY2006 · AR · contact PI
Modulation of Muscle Growth for the Muscular Dystrophies$1,662,366
U54 · FY2005 · AR
CARDIAC GENE THERAPY$411,439
P01 · FY2005 · HL
Structure and Function of Myosin VI$403,640
R01 · FY2005 · AR
Understanding and Preventing Disuse Atrophy$384,363
R01 · FY2005 · AR
Muscle: Contractile Proteins GRC 2005$22,000
R13 · FY2005 · AR
BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHY$699,965
R01 · FY2004 · AR
Structure and Function of Myosin VI$423,009
R01 · FY2004 · AR
CARDIAC GENE THERAPY$400,484
P01 · FY2004 · HL
Understanding and Preventing Disuse Atrophy$384,363
R01 · FY2004 · AR
New Directions in Biology and Disease of Skeletal Muscle$10,000
U13 · FY2004 · AR
BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHY$681,377
R01 · FY2003 · AR
Structure and Function of Myosin VI$413,976
R01 · FY2003 · AR
Understanding and Preventing Disuse Atrophy$384,363
R01 · FY2003 · AR
MYOSIN ISOZYMES$363,077
R01 · FY2003 · AR
TRAINING IN MUSCLE BIOLOGY$167,450
T32 · FY2003 · AR
New Directions in Biology and Disease of Skeletal Muscle$30,000
U13 · FY2003 · AR
BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHY$663,440
R01 · FY2002 · AR
Structure and Function of Myosin VI$419,832
R01 · FY2002 · AR
MYOSIN ISOZYMES$352,500
R01 · FY2002 · AR
IN VIVO STUDIES OF TROPONIN T FUNCTION$310,279
R01 · FY2002 · HL
CARDIAC GENE THERAPY$126,320
P01 · FY2002 · HL
TRAINING IN MUSCLE BIOLOGY$122,954
T32 · FY2002 · AR
DESIGN AND TUNING OF THE SMOOTH/NONMUSCLE MYOSIN MOTOR$0
P01 · FY2002 · HL
CORE--PROTEIN ENGINEERING$0
P01 · FY2002 · HL
BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHY$649,379
R01 · FY2001 · AR
MYOSIN ISOZYMES$342,236
R01 · FY2001 · AR
TRAINING IN MUSCLE BIOLOGY$126,323
T32 · FY2001 · AR
Molecular Motors$15,000
R13 · FY2001 · AR
CORE--PROTEIN ENGINEERING$0
P01 · FY2001 · HL
CARDIAC GENE THERAPY$0
P01 · FY2001 · HL
DESIGN AND TUNING OF THE SMOOTH/NONMUSCLE MYOSIN MOTOR$0
P01 · FY2001 · HL
BIOENGINEERING RESEARCH PARTNERSHIP--MUSCULAR DYSTROPHY$639,745
R01 · FY2000 · AR
MYOSIN ISOZYMES$332,265
R01 · FY2000 · AR
CORE--PROTEIN ENGINEERING$288,917
P01 · FY2000 · HL
DESIGN AND TUNING OF THE SMOOTH/NONMUSCLE MYOSIN MOTOR$288,917
P01 · FY2000 · HL
CARDIAC GENE THERAPY$250,769
P01 · FY2000 · HL
TRAINING IN MUSCLE BIOLOGY$113,324
T32 · FY2000 · AR
GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY$79,085
P01 · FY2000 · AR
ASSESSMENT OF DYSTROPHIN FUNCTION$0
P01 · FY2000 · AR